Pre-earnings options volume in Reviva Pharmaceuticals Holdings is normal with puts leading calls 10:3. Implied volatility suggests the market is anticipating a move near 7.7%, or 0c, after results are released. Median move over the past eight quarters is 15.2%.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on RVPH:
- Reviva Pharmaceuticals Holdings options imply 10.5% move in share price post-earnings
- Reviva Pharmaceuticals Holdings, Inc. (RVPH) Q3 Earnings Cheat Sheet
- Reviva Pharmaceuticals price target raised to $20 from $10 at H.C. Wainwright
- Reviva data robust across multiple endpoints, says Roth MKM
- Reviva Announces Positive Topline Results from Global Pivotal Phase 3 RECOVER Trial of Brilaroxazine in Schizophrenia